"I am also aggressively working to greatly expand our relationships with pharmaceutical companies around the world. I believe that 2013 will be a breakthrough year for increased exposure of Sucanon into new markets. Our product is the only Type II Diabetes drug with no side effects and high efficacy. This incredible combination of attributes is the key strength of our company.""In conclusion, I would like to say that we have been working very hard to increase our market penetration in turbulent corporate times. I believe we are now well positioned to move forward as a company in a more aggressive way. I look forward to 2013 and beyond!"
Fero Industries, Inc. Issues Corporate Update
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.